Cosette Drug Patent Portfolio
Cosette owns 8 orange book drugs protected by 38 US patents with Evoxac having the least patent protection, holding only 1 patent. And Welchol with maximum patent protection, holding 26 patents. Given below is the list of Cosette's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590209 | Use of bremelanotide in patients with controlled hypertension | 29 Apr, 2041 | Active |
| US10286034 | Uses of bremelanotide in therapy for female sexual dysfunction | 05 Nov, 2033 | Active |
| US9352013 | Uses of bremelanotide in therapy for female sexual dysfunction | 05 Nov, 2033 | Active |
| US9700592 | Uses of bremelanotide in therapy for female sexual dysfunction | 05 Nov, 2033 | Active |
| US6794489 | Compositions and methods for treatment of sexual dysfunction | 28 Jun, 2025 | Active |
| US8404703 | Medicinal compositions containing aspirin | 02 Jul, 2023 | Expired |
| US8569325 | Method of treatment with coadministration of aspirin and prasugrel | 02 Jul, 2023 | Expired |
| US8569325 | Method of treatment with coadministration of aspirin and prasugrel | 02 Jan, 2023 | Expired |
| US7229613 | Method for lowering serum glucose | 17 Oct, 2022 | Expired |
| US6878703 | Pharmaceutical composition | 19 May, 2022 | Expired |
| US7229613 | Method for lowering serum glucose | 17 Apr, 2022 | Expired |
| US8404703 | Medicinal compositions containing aspirin | 02 Mar, 2022 | Expired |
| US6878703 | Pharmaceutical composition | 19 Nov, 2021 | Expired |
| US6693115 | Acid addition salts of hydropyridine derivatives | 03 Jul, 2021 | Expired |
| US6579968 | Compositions and methods for treatment of sexual dysfunction | 28 Jun, 2021 | Expired |
| US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | 14 Oct, 2017 | Expired |
| US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | 14 Apr, 2017 | Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use | 25 Oct, 2016 | Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use | 25 Apr, 2016 | Expired |
| US5693675 | Alkylated amine polymers | 02 Jun, 2015 | Expired |
| US5607669 | Amine polymer sequestrant and method of cholesterol depletion | 10 Dec, 2014 | Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion | 10 Dec, 2014 | Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Dec, 2014 | Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Dec, 2014 | Expired |
| US5693675 | Alkylated amine polymers | 02 Dec, 2014 | Expired |
| US5679717 | Method for removing bile salts from a patient with alkylated amine polymers | 29 Oct, 2014 | Expired |
| US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Oct, 2014 | Expired |
| US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Oct, 2014 | Expired |
| US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Oct, 2014 | Expired |
| US5607669 | Amine polymer sequestrant and method of cholesterol depletion | 10 Jun, 2014 | Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion | 10 Jun, 2014 | Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Jun, 2014 | Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor | 10 Jun, 2014 | Expired |
| US5679717 | Method for removing bile salts from a patient with alkylated amine polymers | 29 Apr, 2014 | Expired |
| US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Apr, 2014 | Expired |
| US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Apr, 2014 | Expired |
| US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor | 29 Apr, 2014 | Expired |
| US5340821 | Composition and method for treating Sjoegren syndrome disease | 07 Jul, 2013 | Expired |
Latest Legal Activities on Cosette's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cosette.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 19 Nov, 2023 | US9352013 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 17 Nov, 2023 | US9352013 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Feb, 2023 | US11590209 |
|
Email Notification
Critical
| 28 Feb, 2023 | US11590209 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Feb, 2023 | US11590209 |
|
Issue Notification Mailed
Critical
| 08 Feb, 2023 | US11590209 |
| Dispatch to FDC | 26 Jan, 2023 | US11590209 |
|
Application Is Considered Ready for Issue
Critical
| 26 Jan, 2023 | US11590209 |
|
Issue Fee Payment Received
Critical
| 24 Jan, 2023 | US11590209 |
|
Issue Fee Payment Verified
Critical
| 24 Jan, 2023 | US11590209 |
|
Email Notification
Critical
| 26 Oct, 2022 | US11590209 |
|
Mail Notice of Allowance
Critical
| 26 Oct, 2022 | US11590209 |
|
Electronic Review
Critical
| 26 Oct, 2022 | US11590209 |
|
Notice of Allowance Data Verification Completed
Critical
| 22 Oct, 2022 | US11590209 |
| Date Forwarded to Examiner | 16 Sep, 2022 | US11590209 |
Cosette's Drug Patent Litigations
Cosette's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jun 26, 2015, against patent number US8569325. The petitioner Panacea Biotec Ltd., challenged the validity of this patent, with DAIICHI SANKYO COMPANY, LIMITED as the respondent. Click below to track the latest information on how companies are challenging Cosette's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8404703 | March, 2015 |
FWD Entered
(12 Sep, 2016)
| DAIICHI SANKYO COMPANY, LIMITED | Accord Healthcare Inc., USA |
| US8404703 | October, 2015 |
FWD Entered
(12 Sep, 2016)
| Daiichi Sankyo Co., Ltd. | Lupin, Ltd. |
| US8569325 | March, 2015 |
FWD Entered
(12 Sep, 2016)
| DAIICHI SANKYO COMPANY, LIMITED | Accord Healthcare Inc., USA |
| US8569325 | October, 2015 |
FWD Entered
(12 Sep, 2016)
| Daiichi Sankyo Co., Ltd. | Lupin, Ltd. |
| US8404703 | June, 2015 |
Terminated-Denied
(07 Jan, 2016)
| DAIICHI SANKYO COMPANY, LIMITED | Panacea Biotec Ltd. |
| US8569325 | June, 2015 |
Terminated-Denied
(07 Jan, 2016)
| DAIICHI SANKYO COMPANY, LIMITED | Panacea Biotec Ltd. |
Cosette Drug Patents' Oppositions Filed in EPO
Cosette drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 18, 2019, by Teva Pharmaceutical Industries Ltd.. This opposition was filed on patent number EP13851014A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP13851014A | Jun, 2019 | Teva Pharmaceutical Industries Ltd. | Granted and Under Opposition |
Cosette's Family Patents
Cosette Drug List
Given below is the complete list of Cosette's drugs and the patents protecting them.
1. Azor
Azor is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(8 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Azor's drug page
2. Benicar
Benicar is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6878703
(Pediatric)
| Pharmaceutical composition |
19 May, 2022
(2 years ago)
| Expired |
| US6878703 | Pharmaceutical composition |
19 Nov, 2021
(2 years ago)
| Expired |
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(8 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Benicar's drug page
3. Benicar Hct
Benicar Hct is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6878703
(Pediatric)
| Pharmaceutical composition |
19 May, 2022
(2 years ago)
| Expired |
| US6878703 | Pharmaceutical composition |
19 Nov, 2021
(2 years ago)
| Expired |
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(8 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Benicar Hct's drug page
4. Effient
Effient is protected by 7 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8404703
(Pediatric)
| Medicinal compositions containing aspirin |
02 Jul, 2023
(1 year, 4 months ago)
| Expired |
| US8569325
(Pediatric)
| Method of treatment with coadministration of aspirin and prasugrel |
02 Jul, 2023
(1 year, 4 months ago)
| Expired |
| US8569325 | Method of treatment with coadministration of aspirin and prasugrel |
02 Jan, 2023
(1 year, 10 months ago)
| Expired |
| US8404703 | Medicinal compositions containing aspirin |
02 Mar, 2022
(2 years ago)
| Expired |
| US6693115 | Acid addition salts of hydropyridine derivatives |
03 Jul, 2021
(3 years ago)
| Expired |
| US5288726
(Pediatric)
| Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
14 Oct, 2017
(7 years ago)
| Expired |
| US5288726 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation |
14 Apr, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Effient's drug page
5. Evoxac
Evoxac is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5340821 | Composition and method for treating Sjoegren syndrome disease |
07 Jul, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoxac's drug page
Explore Our Curated Drug Screens
6. Tribenzor
Tribenzor is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5616599
(Pediatric)
| Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Oct, 2016
(8 years ago)
| Expired |
| US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
25 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tribenzor's drug page
7. Vyleesi (autoinjector)
Vyleesi (autoinjector) is protected by 6 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590209 | Use of bremelanotide in patients with controlled hypertension |
29 Apr, 2041
(16 years from now)
| Active |
| US10286034 | Uses of bremelanotide in therapy for female sexual dysfunction |
05 Nov, 2033
(8 years from now)
| Active |
| US9352013 | Uses of bremelanotide in therapy for female sexual dysfunction |
05 Nov, 2033
(8 years from now)
| Active |
| US9700592 | Uses of bremelanotide in therapy for female sexual dysfunction |
05 Nov, 2033
(8 years from now)
| Active |
| US6794489 | Compositions and methods for treatment of sexual dysfunction |
28 Jun, 2025
(7 months from now)
| Active |
| US6579968 | Compositions and methods for treatment of sexual dysfunction |
28 Jun, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vyleesi (autoinjector)'s drug page
8. Welchol
Welchol is protected by 26 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7229613
(Pediatric)
| Method for lowering serum glucose |
17 Oct, 2022
(2 years ago)
| Expired |
| US7229613 | Method for lowering serum glucose |
17 Apr, 2022
(2 years ago)
| Expired |
| US5693675
(Pediatric)
| Alkylated amine polymers |
02 Jun, 2015
(9 years ago)
| Expired |
| US5607669
(Pediatric)
| Amine polymer sequestrant and method of cholesterol depletion |
10 Dec, 2014
(9 years ago)
| Expired |
| US5919832
(Pediatric)
| Amine polymer sequestrant and method of cholesterol depletion |
10 Dec, 2014
(9 years ago)
| Expired |
| US6066678
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
10 Dec, 2014
(9 years ago)
| Expired |
| US6433026
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
10 Dec, 2014
(9 years ago)
| Expired |
| US5693675 | Alkylated amine polymers |
02 Dec, 2014
(9 years ago)
| Expired |
| US5679717
(Pediatric)
| Method for removing bile salts from a patient with alkylated amine polymers |
29 Oct, 2014
(10 years ago)
| Expired |
| US5917007
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(10 years ago)
| Expired |
| US5919832
(Pediatric)
| Amine polymer sequestrant and method of cholesterol depletion |
29 Oct, 2014
(10 years ago)
| Expired |
| US6066678
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(10 years ago)
| Expired |
| US6433026
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(10 years ago)
| Expired |
| US6784254
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(10 years ago)
| Expired |
| US7101960
(Pediatric)
| Process for removing bile salts from a patient and alkylated compositions therefor |
29 Oct, 2014
(10 years ago)
| Expired |
| US5607669 | Amine polymer sequestrant and method of cholesterol depletion |
10 Jun, 2014
(10 years ago)
| Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
10 Jun, 2014
(10 years ago)
| Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
10 Jun, 2014
(10 years ago)
| Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
10 Jun, 2014
(10 years ago)
| Expired |
| US5679717 | Method for removing bile salts from a patient with alkylated amine polymers |
29 Apr, 2014
(10 years ago)
| Expired |
| US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(10 years ago)
| Expired |
| US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
29 Apr, 2014
(10 years ago)
| Expired |
| US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(10 years ago)
| Expired |
| US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(10 years ago)
| Expired |
| US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(10 years ago)
| Expired |
| US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor |
29 Apr, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Welchol's drug page